Breckenridge Pharmaceutical, Inc. is a Towa Company.
We are an own label distributor that performs pharmaceutical marketing, sales and distribution in the U.S. The company was founded in 1983 and markets a broad range of generic prescription products in several therapeutic categories and dosage forms, including tablets, capsules, liquids, suspensions, ophthalmics, nasal sprays, powders, transdermal patches, and injectable products.
The Breckenridge label is recognized nationwide by wholesalers, distributors, chains, managed care accounts, and retail pharmacies.
Breckenridge, headquartered in Berlin, Connecticut, markets products under more than 40 Abbreviated New Drug Applications (ANDAs) approved by the Food and Drug Administration (FDA).